chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart palpitations and mild chest pain above the heart.  Sensation of the heart beating harder than normal, regardless of activity level.  Discomfort when sleeping on sides due to increased perceived pressure on heart.  Acute chest pain (though still relatively mild) subsided after the first day, but minor discomfort persists after 10 days (as of reporting).
Moderna COVID-19 Vaccine EUA Severe sinus reaction - sneezing, congestion, runny nose, chest pain from excessive sneezing.
Dose that was administered expired on 7-5-2021. No adverse side effects were noted at time of vaccination.
ARM SORENESS, SWELLING AT INJECTION SITE Narrative:  EMPLOYEE STATES: ARM WAS SORE UPON GOING TO BED, THE NEXT MORNINGSWELLING AT INJECTION SITE, SWELLING INCREASED THROUGHOUT THE DAY TO AN AREA THE SIZE OF A HAND. THE AREA IS HARD AND SORE TO TOUCH LIKE IT IS PULLING ON A MUSCLE
HAD MMRV 5/4/07 AND BROKE OUT IN RASH 5/11/07.SKIN REDDISH,PAPULAR/MACULAR TO VERSICULAR ERUPTION ALL OVER.
Right after injection felt dizzy immediately. Within minutes chest became tight. blood pressure was taken and read 158/103. pulse ox was 86. evaluated by physician at the vaccine clinic.   took 50 ml of Benadryl.  Close monitoring continued and 02 went up to 95.  Tightness in chest continued throughout the day. Began experiencing abdominal pain approx. 730pm. on 1/13.  At 930pm began with worsening  severe abdominal pain with continued shortness of breath.  At that time, pt. went to the Hospital ER. for evaluation.  In the ER, her pulse ox was in the 90's.  She received Benadryl, lab work, and CT Scan of abdomen, and was discharged to home.   Day 2 pt.  continued to experience  abdominal pain and shortness of breath. The third day fever and chills. Day 4 body aches.  pt. is completely recovered at this time, and is recommended by her health care provider to NOT receive the second dose of the vaccine.  pt. s not taking the second dose of the Moderna vaccine.
Flu like symptoms; side effects consisted of full physical and mental demise.; effects consisted of full physical and mental demise.; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MALAISE (side effects consisted of full physical and mental demise.) and EMOTIONAL DISTRESS (effects consisted of full physical and mental demise.) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MALAISE (side effects consisted of full physical and mental demise.) and EMOTIONAL DISTRESS (effects consisted of full physical and mental demise.). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved and MALAISE (side effects consisted of full physical and mental demise.) and EMOTIONAL DISTRESS (effects consisted of full physical and mental demise.) outcome was unknown. Not Provided          Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD21-065042 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up was received on 26 May 2021 and included new events and the description of the events.; Sender's Comments:  MOD21-065042:
I could barely lift my left arm last night; Been tired and headache all day; Been tired and headache all day; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 53-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 25Aug2023 as dose number unknown, single (Lot number: GD8455) at the age of 53 years, in left arm for immunisation. The patient's relevant medical history included: "Allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), FATIGUE (non-serious) all with onset 26Aug2023, outcome "recovering" and all described as "Been tired and headache all day"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 26Aug2023, outcome "recovering", described as "I could barely lift my left arm last night". Therapeutic measures were not taken as a result of joint range of motion decreased, headache, fatigue.
Moderna COVID-19 Vaccine EUA - Rapid resting heart rate approx 12-14 hours after injection.  Tired/rundown approx 20 hours.
Have ringing in ears that started about 5 days after injection. Did not have previous problem with tinnitus.
Went to stand up after 15 mins of observation. Felt flush, hot, dizzy. Heartrate was irregular per observation RN who was checking pulse. Went to ED, EKG and bloodwork normal, released home.
(L) shoulder with 9 cm area of erythema below injection site flat without induration no sig tenderness local reaction to DTaP.
24 hrs after receiving Pneumovax in left arm area became hot and tender to touch from the elbow to the shoulder, also swelling in left arm, lasting about 36 hours (Friday pm through Sunday PM.
chills; fever; body aches; cough; congestion; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration on 05Feb2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  On an unspecified date in Feb2021 the patient experienced chills, fever, body aches, cough and congestion, all non serious. The final outcome of the event was unknown.No follow-up attempts are possible, information about batch number cannot be obtained.
After receiving the vaccine, I experienced a terrible metallic taste in my mouth and later in the day I had heart palpitations upon arriving home and contacted my PCP who said to go to the ER if the episode happened again. I also had to contact my PCP again when I woke up the next day without the ability to move my arms and she referred me to a Rheumatologist who stated tat she has seen the same symptoms as a delayed side affect of the vaccine.  I took one dose of the Hydroxychloroquine  and I stopped taking it because it caused bleeding in my left ear along with severe pain in the same ear. I then took matters into my own hands and when for physical therapy, medical massage, and acupuncture to relieve the symptoms. I went to a Urologist to perform an EMG to find out what's happening for both arms all the way down to my fingers.in November.
Extensive itchy violet papules/plaques on knees ankles, dorsal foot lower legs dorsal hands, forearms abdomen  Dermatitis
patient developed pleuritic pain , dyspnea, flulike symptoms shortly after receiving 2nd Moderna dose on 05/11/2021. He went to ED 05/13/2021 and was found to have pleural effusion, loculation and pneumonia and transferred to another hospital were he underwent 2 pigtail catheter placement.  He had negative Covid testing and negative cultures. No surgical intervention required. All cultures, AFB and SARS COV 2 testing were apparently negative(per intial hospitalization DS) though results are not available. unknown if cytology was completed.  Patient seen by this provider to review labs and screening CT chest on 04/28. He was asymptomatic at that time. CT chest dated 03/31/2021 showed minimal stable bibasilar subsegmental atelectasis and/or linear fibrosis unchanged from previous year. He reported receiving his 1st Covid 19 vaccination on 04/18 without side effects . On may 11th he received his second covid 19 vaccination and later that day reports he developed cough and right sided rib pain worse with coughing and deep breathing. The following day he felt like he "was run over by a truck" with increased cough, pleuritic pain, malaise and dyspnea.
Sore; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore; Pain at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore; Pain at injection site). At the time of the report, VACCINATION SITE PAIN (Sore; Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment and concomitant medication information reported.
Large rash developed with bruising in the center. Patient reports sensitivity on skin as well as slightly irritation and itchiness.
Patient complained of dizziness following vaccination. Patient was placed in a supine position with legs elevated. Patient's blood pressure was checked and reported at 110/70. After a few minutes patient reported feeling fine. Patient was observed for 15 minutes then released to her husband.
At approximately 1505 this 38 yo white female displayed seizure type activity while sitting in the observation stating at the mobile vaccine clinic. Staff safely lowered her from chair to side lying position. Seizure activity observed for less than one minute, drooling noted. Post-ictal for approximately 5 min AEB delay in response to questions, following directions and formulating complete sentences. Neuro: PERRLA, hand grips equal, lower extremity strength strong and equal bilat. EMS services arrived, took charge, assessed and put pt on transport gurney but she declined transport. EMS staff stated familiarity with pt and seizure history. She remained in observation for 30 min longer VSS with BP 120/82, R 20, P 90.
pt recvd vax 25APR92 & exp toxemia, hypertension & preeclampsia; 6JAN93 pt delivered a 5 lb 8oz male infant; the child exp apnea, brain hemmorrhage, scalp ecchymosis & hyperbilirubinemia;
sore arm; A spontaneous report (United States) was received from a Reporter concerning about male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events (PT term) list.  The patient's medical history was not provided. No relevant concomitant medications were reported.  Patient reported sore arm upon injection No treatment details was provided Action taken with mRNA-1273 in response to the events was not reported.
Patient complains of adverse effect of other and unspecified vaccines and biological substances. It began 2 days ago. It is of mild intensity. This is the first episode. The typical duration of an episode is the majority of the day. Aggravating factors include is getting worse since first noticed. Nothing relieves symptoms. Associated symptoms include pain, rash, swelling and at site of vaccine injection left ant thigh. He denies fever.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 and included treatment with PF-07321332, ritonavir (PAXLOVID).  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Extreme fatigue; Bilateral axillary lymph node swelling; Hot/cold sweats; Supraclavicular left sided swelling; Hot/cold sweats; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 1840707-03792) via an unspecified route of administration in the left arm on 27Sep2021 at 12:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid, polycystic ovarian syndrome (PCOS), postural orthostatic tachycardia syndrome (POTTS), ehlers-danlos syndrome (EDS) and eosinophilic esophagitis (EOE). The patient had known allergies to eggs, milk, fish, peanuts, lobster, gluten and penicillin. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), liothyronine sodium (CYTOMEL) and ethinylestradiol/norethisterone acetate (LOESTRIN); all for unknown indications from an unknown date and unknown if ongoing. The patient previously took amoxicillin/clavulanic acid (AUGMENTIN) on an unknown date and experienced drug allergy. On 29Sep2021 at 05:30, the patient experienced extreme fatigue, bilateral axillary lymph node swelling, supraclavicular left sided swelling and hot/cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, bilateral axillary lymph node swelling, supraclavicular left sided swelling, hot/cold sweats was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
C/O lightheadedness, skin pale, nausea, vomiting. Laid pt flat and elevated feet, turned to the side after vomiting stopped. Offered Gatorade and pretzels. BP 124/82, HR 62, R16, T 97.2 orally. Was DC'd home with mother ambulating/denied any complaints.
(L) arm - red swollen area around injection site. Rx: Ibuprofen, topical triamcinolone oint 0.1%.
Patient was administered with 0.25mL instead of 0.5mL of bivalent booster dose; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered with 0.25mL instead of 0.5mL of bivalent booster dose) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered with 0.25mL instead of 0.5mL of bivalent booster dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered with 0.25mL instead of 0.5mL of bivalent booster dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered with 0.25mL instead of 0.5mL of bivalent booster dose).    No concomitant medication was reported.  It was reported that 100 patients were administered an invalid dose of Moderna COVID-19 bivalent booster. The nurse had no standing order other than what they had for second booster, when administering bivalent boosters, so they assumed same dose as second booster and administered 0.25ml to uncompromised adults.  This case was for one of the patient among the 100 patients who were administered an invalid dose of Moderna COVID-19 bivalent booster.    It was reported that CDC had recommended to revaccinate the patients with full dose of 0.5mL.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-646512 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-646512:Master case
Sore arm; Body chills; Headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 07May2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 02:00, the patient experienced sore arm, body chills and headache. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm, body chills and headache were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Left swollen, red, hot to touch arm badly noted 11:30, 06/16/2005 - Immunization given approximately 11:30 06/15/2005.
This spontaneous report as received from a medical assistant refers to a 4 month old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 05-OCT-2018, the patient was vaccinated with improperly stored dose of ROTATEQ 2 ml tube, orally (lot # N022015, expiry date: 10-MAR-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) and time frame was 3.5 hours from 06-SEP-2018. Previous excursion was 50.37 °F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868:Original Case : 1809USA002868 US-009507513-1902USA009324:Original Case : 1902USA009323US-009507513-1902USA009323:Original Case : 1902USA009323 US-009507513-1902USA009326:Original Case : 1902USA009323.
Saw primary care on 2/14/14 c/o of fever 103 degrees. (R) upper arm, tender with swollen lymphatics, began hours after injections and lasted x 3 days.
DONOR STATED THAT HE HAD FLU LIKE SYMPTOMS X2 DAYS AFTER RECEIVING TETANUS IMMUNIZATION. DONOR ONLY FELT THIS WAY FOR THE DAY AND NOW HE FEEL FINE.
At approximately 4:41 PM, patient sustained episode of syncope with seizure activity. Patient regained consciousness and then had additional episode of syncope.   At 4:45 PM, VITALS BP 98/42, HR 60, RR 20, O2 99%.   EMS called, HR 50, O2 97% with persistent diaphoresis without nausea. Patient A&O x4 and conversant with staff.  EMS arrived at 5:00 PM and assumed care, Patient declined EMS visit and significant other took her home.  Significant other on scene reports that patient has history of syncope with blood drawns
TC 8AM 10NOV94 from mom pt c/o moderate to severe h/a behind eyes & ears, neck ache, face flet warm; (no theromemter available) mom stated also had chills & c/o dizziness; reamined w/sx @ time of phone call; advised mom to go to MD;
brachial neuritis, pain in arm immed p/vax;aching severe in shoulder & arm-in side as inj numbness that is getting progressively worse;weakness in arm;
First reported symptoms on 1/19 and again on 1/31/14. Symptoms of pain down arm, problem lifting, and decreased fine motor skill in hand. Slow improvement over 1/19 - 1/31 time frame. Tried icing and OTC pain meds. Has not seen physician yet.
CoughWheeze & UrticariaPruritus Narrative;  Itching was recurrent when benadryl wears off  Other Relevant History:
Fever. Chills. Muscle strength. Pain in diaphragm and right arm. Chattering teeth. Head ache (excruciating). BENADRYL helped.
pt recvd vax; exp sz immediately following vax;prior to sz, felt lightheaded & fainted; on MD's table, arms & legs were twitching, eyes fixed; no tx;
This case was reported by a nurse via call center representative and described the occurrence of extremities hot feeling of in a 11-year-old female patient who received MENVEO (batch number M16159, expiry date 31st October 2018). On 25th August 2017, the patient received MENVEO (subcutaneous) .5 ml. In August 2017, 1 day 12 hrs after receiving MENVEO, the patient experienced extremities hot feeling of, pain in arm, injection site bruising, swelling arm and erythema of extremities. On 25th August 2017, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the extremities hot feeling of, pain in arm, injection site bruising and erythema of extremities were recovering/resolving and the outcome of the swelling arm and intramuscular formulation administered by other route were unknown. The reporter considered the extremities hot feeling of, pain in arm, injection site bruising, swelling arm and erythema of extremities to be almost certainly related to MENVEO. Additional details were reported as follows: The patient was inadvertently vaccinated with MENVEO subcutaneously, which led to inappropriate route of vaccine administration. The patient subsequently experienced a horrific local reaction. Less than a day after vaccination, the patient experienced injection site bruising and arm redness. The patient first reported the reaction to her mother 24 hours after vaccination, but the healthcare professional was uncertain exactly when the reaction actually began.
She received her first Moderna Covid 19 vaccine through PAMF on 1/16 in left arm. Had some mild tenderness at injection site same day and following day but was minimal.   1 week later on 1/23 upper left arm started to bother, hurt more. Felt itchy over area of vaccine site. No blisters. Redness spread to lower upper arm but is improving in past 2 days.  Treating with apap, Advil and benadryl- helps  Improving but wanted area checked  She did some research online and was able to speak to a Moderna representative  and told should see her pcp and be checked to make sure area was not infected  Was also told of a form her pcp could complete online to document her reaction and send to Moderna  Denies having any breathing issues, hives or n/v related to Moderna vaccine  Arm symptoms continue to improve
Client thought that vanish point needle broke off in left deltoid, denied pain. Found on further examination that needle point was not in clients arm. Client was not injured.
I woke on 12/25/2021 with a sore throat and was under the weather. My daughter had a COVID 19 test kit and I took it and it was positive. I bought another COVID 19 test from the pharmacy and that was also positive. I had a fever that stayed with me for about 10 days. It was a low grade fever around 99.4 degrees. After one week I was feeling better. My doctor advised me to quarantine. I did not go to the doctor, I stayed home and quarantined for 14 days.